Volume 145, Issue 5, Pages (November 2013)

Slides:



Advertisements
Similar presentations
Volume 146, Issue 2, Pages (February 2014)
Advertisements

Volume 66, Issue 6, Pages (June 2013)
Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic mice  Ying Wang,
Volume 148, Issue 7, Pages e3 (June 2015)
Volume 143, Issue 4, Pages e4 (October 2012)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 132, Issue 2, Pages (February 2007)
Volume 143, Issue 5, Pages (November 2012)
Volume 137, Issue 4, Pages (October 2009)
Volume 140, Issue 2, Pages e1 (February 2011)
Volume 140, Issue 7, Pages (June 2011)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 134, Issue 5, Pages e1 (May 2008)
Volume 138, Issue 4, Pages (April 2010)
Volume 137, Issue 3, Pages e7 (September 2009)
Volume 143, Issue 4, Pages e9 (October 2012)
Effectiveness of Hepatitis B Treatment in Clinical Practice
Volume 137, Issue 2, Pages (August 2009)
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Volume 134, Issue 5, Pages (May 2008)
Volume 141, Issue 5, Pages (November 2011)
Volume 134, Issue 1, Pages (January 2008)
Volume 141, Issue 4, Pages e2 (October 2011)
Making Sense of HDAC2 Mutations in Colon Cancer
Volume 134, Issue 5, Pages (May 2008)
Volume 143, Issue 3, Pages (September 2012)
Volume 135, Issue 4, Pages (October 2008)
Volume 138, Issue 4, Pages (April 2010)
Volume 150, Issue 4, Pages (April 2016)
Volume 143, Issue 6, Pages e4 (December 2012)
Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors  Dominique Challine, Stéphane Chevaliez,
Volume 151, Issue 5, Pages e4 (November 2016)
Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome  Caroline Pical-Izard, Roberto.
Volume 137, Issue 2, Pages (August 2009)
Volume 142, Issue 7, Pages e3 (June 2012)
Volume 153, Issue 5, Pages e2 (November 2017)
Volume 134, Issue 7, Pages e2 (June 2008)
Masanori Isogawa, Yoshihiro Furuichi, Francis V. Chisari  Immunity 
Volume 137, Issue 5, Pages (November 2009)
The IL23R A/Gln381 Allele Promotes IL-23 Unresponsiveness in Human Memory T- Helper 17 Cells and Impairs Th17 Responses in Psoriasis Patients  Paola Di.
Volume 132, Issue 2, Pages (February 2007)
Volume 135, Issue 6, Pages (December 2008)
Volume 141, Issue 5, Pages e2 (November 2011)
Volume 144, Issue 2, Pages (February 2013)
Volume 134, Issue 7, Pages e3 (June 2008)
Volume 138, Issue 2, Pages e4 (February 2010)
Volume 140, Issue 4, Pages (April 2011)
Volume 144, Issue 2, Pages (February 2013)
Volume 143, Issue 1, Pages e3 (July 2012)
Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins  Harel Dahari, Stephen M. Feinstone,
Efficient Early Drug Development for Ulcerative Colitis
Percy A. Knolle, Robert Thimme  Gastroenterology 
Allison K. Martin, BS, Douglas G. Mack, PhD, Michael T
Volume 127, Issue 3, Pages (September 2004)
Volume 134, Issue 7, Pages e2 (June 2008)
Vaccinating Against Helicobacter pylori: Dissecting the Mechanism
Volume 117, Issue 6, Pages (December 1999)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 152, Issue 1, Pages (January 2017)
Will There Be a Vaccine to Protect Against the Hepatitis C Virus?
Volume 147, Issue 4, Pages e8 (October 2014)
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Volume 135, Issue 3, Pages (September 2008)
Covering the Cover Gastroenterology
Volume 156, Issue 3, Pages (February 2019)
Volume 131, Issue 6, Pages (December 2006)
Volume 142, Issue 7, Pages e6 (June 2012)
The Majority of Epidermal T Cells in Psoriasis Vulgaris Lesions can Produce Type 1 Cytokines, Interferon-γ, Interleukin-2, and Tumor Necrosis Factor-α,
Volume 138, Issue 2, Pages e4 (February 2010)
Presentation transcript:

Volume 145, Issue 5, Pages 1026-1034 (November 2013) The Hepatitis B Vaccine Protects Re-Exposed Health Care Workers, But Does Not Provide Sterilizing Immunity  Jens M. Werner, Adil Abdalla, Naveen Gara, Marc G. Ghany, Barbara Rehermann  Gastroenterology  Volume 145, Issue 5, Pages 1026-1034 (November 2013) DOI: 10.1053/j.gastro.2013.07.044 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 HBs-induced antibody responses correlate with HBs-specific T-cell responses but not with time after vaccination. (A) Characterization of the vaccinee cohort. HBs-specific antibody responses were tested by EIA and T-cell responses by ELISpot. Number and percentage of vaccinees with (shaded areas) and without (clear area) HBs-specific T-cell responses at the time of this study are indicated in the pie chart. The blue band around the circle represents the subgroup of vaccinees with anti-HBs responses >12 mIU/mL. (B) Correlation between the strength of the HBs-specific IFN-γ+ T-cell response and HBs-specific antibody response of health care workers tested 10 to 28 years after vaccination. (C, D) Correlation between the HBs-specific antibody response (C) or the strength of the HBs-specific IFN-γ+ T-cell response (D) and the time after vaccination. Statistical analysis: nonparametric, Spearman correlation. The dotted line indicates an antibody level of 12 mIU/mL. Gastroenterology 2013 145, 1026-1034DOI: (10.1053/j.gastro.2013.07.044) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Occupational HBV exposure induces HBcore- and HBpol-specific T-cell-responses, despite prior HBsAg vaccination. The prevalence (left graphs) and strength (middle and right graphs) of HBV-specific T-cell responses were determined against (A) HBcore peptides, (B) HBVpol peptides, and (C) HDV control peptides in 90 vaccinees who were stratified by post-vaccination HBV exposure score, and 25 nonvaccinated patients, who had recovered from acute HBV infection. Results in the left and middle graphs were obtained by IFN-γ ELISpot assay, and results in the right graphs were obtained by intracellular cytokine staining. Means ± SEM are indicated in the middle graphs and in the right graphs. Statistical analysis: χ2 and Fisher's exact test were used to compare the prevalence of responses (left graphs). The nonparametric Kruskal–Wallis test with Dunn's multiple comparison was used to compare the strength of responses (middle and right graphs). Gastroenterology 2013 145, 1026-1034DOI: (10.1053/j.gastro.2013.07.044) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Occupational HBV exposure induces HBcore- and HBVpol-specific CD8 T cells. The prevalence (left graphs) and strength (right graphs) of HBV-specific CD8 T-cell responses were determined against (A) HBcore peptides, (B) HBVpol peptides, and (C) HDV control peptides in 90 vaccinees, who were stratified by post-vaccination HBV exposure score, and in 24 nonvaccinated patients, who had recovered from acute HBV infection. Results were obtained by intracellular cytokine staining. Means ± SEM are indicated. Statistical analysis: χ2 and Fisher's exact test were used to compare the prevalence of responses (left graphs). The nonparametric Kruskal–Wallis test with Dunn's multiple comparison was used to compare the strength of responses (right graphs). Gastroenterology 2013 145, 1026-1034DOI: (10.1053/j.gastro.2013.07.044) Copyright © 2013 AGA Institute Terms and Conditions

Figure 4 Occupational HBV exposure after vaccination does not affect HBs-specific T-cell and antibody responses. Prevalence and strength of IFN-γ+ T-cell responses (A) and antibody responses (B) against HBs in 90 vaccinees who were stratified by post-vaccination HBV exposure score, 25 nonvaccinated patients, who had recovered from acute HBV infection, and 10 nonvaccinated subjects. Statistical analysis: χ2 and Fisher's exact test were used to compare the prevalence of responses (left graphs). The nonparametric Kruskal–Wallis test with Dunn's multiple comparison and the Mann–Whitney test were used to compare the strength of responses (right graphs). Means ± SEM are shown in the right graphs. Gastroenterology 2013 145, 1026-1034DOI: (10.1053/j.gastro.2013.07.044) Copyright © 2013 AGA Institute Terms and Conditions

Figure 5 Most vaccine-induced CD4 T cells are terminally differentiated, and most exposure-induced CD4 T cells are effector memory cells. (A) Gating strategy. (B) Percentage of terminally differentiated effector T cells (CD45RO−CCR7−CD127−) and effector memory T cells (CD45RO+CCR7−CD127−) within the CD69+IFN-γ+ CD4 T-cell population after stimulation with either HBs or HBcore/pol-peptides. Means ± SEM of data from 36 vaccinees and from 13 patients recovered from acute HBV are shown. Statistical analysis: unpaired t test. Gastroenterology 2013 145, 1026-1034DOI: (10.1053/j.gastro.2013.07.044) Copyright © 2013 AGA Institute Terms and Conditions